This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Oct;20(4):305-6.

doi: 10.1016/s0924-8579(02)00185-1.

Phenothiazines and prion diseases: a potential mechanism of action towards oxidative stress

PMID: 12385690
DOI: 10.1016/s0924-8579(02)00185-1

Comment

Phenothiazines and prion diseases: a potential mechanism of action towards oxidative stress

Ammar Achour. Int J Antimicrob Agents. 2002 Oct.

. 2002 Oct;20(4):305-6.

doi: 10.1016/s0924-8579(02)00185-1.

Author

PMID: 12385690
DOI: 10.1016/s0924-8579(02)00185-1

No abstract available

PubMed Disclaimer

Comment on

Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants.
Amaral L, Kristiansen JE. Amaral L, et al. Int J Antimicrob Agents. 2001 Nov;18(5):411-7. doi: 10.1016/s0924-8579(01)00432-0. Int J Antimicrob Agents. 2001. PMID: 11711254 Review.

Similar articles

Multiple non-psychiatric effects of phenothiazines: a review.
Sudeshna G, Parimal K. Sudeshna G, et al. Eur J Pharmacol. 2010 Dec 1;648(1-3):6-14. doi: 10.1016/j.ejphar.2010.08.045. Epub 2010 Sep 7. Eur J Pharmacol. 2010. PMID: 20828548 Review.
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.
Korth C, May BC, Cohen FE, Prusiner SB. Korth C, et al. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9836-41. doi: 10.1073/pnas.161274798. Proc Natl Acad Sci U S A. 2001. PMID: 11504948 Free PMC article.
Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown DR. Brown DR. Folia Neuropathol. 2005;43(4):229-43. Folia Neuropathol. 2005. PMID: 16416388 Review.
Cancer therapy: phenothiazines in an unexpected role.
Jones GR. Jones GR. Tumori. 1985 Dec 31;71(6):563-9. doi: 10.1177/030089168507100608. Tumori. 1985. PMID: 3909565 Review.
Antimicrobial activity of phenothiazines.
Amaral L, Viveiros M, Molnar J. Amaral L, et al. In Vivo. 2004 Nov-Dec;18(6):725-31. In Vivo. 2004. PMID: 15646813 Review.

See all similar articles

Cited by

Ruthenium(II)-N-alkyl phenothiazine complexes as potential anticancer agents.
Leskovac A, Petrovic S, Lazarevic-Pasti T, Krstic M, Vasic V. Leskovac A, et al. J Biol Inorg Chem. 2018 Jul;23(5):689-704. doi: 10.1007/s00775-018-1560-x. Epub 2018 Apr 11. J Biol Inorg Chem. 2018. PMID: 29644470
Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy.
Vana K, Zuber C, Nikles D, Weiss S. Vana K, et al. Cell Mol Neurobiol. 2007 Feb;27(1):107-28. doi: 10.1007/s10571-006-9121-1. Epub 2006 Dec 7. Cell Mol Neurobiol. 2007. PMID: 17151946 Free PMC article. Review.
Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.
Seghatchian J, Struff WG, Reichenberg S. Seghatchian J, et al. Transfus Med Hemother. 2011;38(1):55-64. doi: 10.1159/000323786. Epub 2011 Jan 27. Transfus Med Hemother. 2011. PMID: 21779206 Free PMC article.
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.
Cicchetti A, Berrino A, Casini M, Codella P, Facco G, Fiore A, Marano G, Marchetti M, Midolo E, Minacori R, Refolo P, Romano F, Ruggeri M, Sacchini D, Spagnolo AG, Urbina I, Vaglio S, Grazzini G, Liumbruno GM. Cicchetti A, et al. Blood Transfus. 2016 Jul;14(4):287-386. doi: 10.2450/2016.0065-16. Blood Transfus. 2016. PMID: 27403740 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science